SELLAS Life Sciences Group, Inc. (SLS) Balance Sheet
As of 2026-06-30 (10-Q), SELLAS Life Sciences Group, Inc. (SLS) reported total assets of $145.4M, total liabilities of $7.7M and shareholders' equity of $137.7M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $138.3M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SLSSELLAS Life Sciences Group, Inc.Follow SLS — free
—
Price chart with a free account
- Market cap
- 2.3B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 47.8 | 32.8 | 47.8 | 23.7 | 1.4 | 6.0 | 2.3 | 5.3 | 7.3 | 35.3 | 21.4 | 17.1 | 2.5 | 13.9 | 71.8 | 138.3 | |
| Receivables | — | 0.0 | 3.7 | 1.8 | — | — | — | — | — | — | 0.0 | — | — | — | — | — | |
| Inventory | — | 0.0 | 0.4 | 0.7 | 0.0 | — | — | — | — | — | — | — | — | — | — | — | |
| Current assets | 11.8 | 36.1 | 53.5 | 52.1 | 53.6 | 6.4 | 13.1 | 5.8 | 8.2 | 36.9 | 23.0 | 17.8 | 3.2 | 16.3 | 75.2 | 142.5 | |
| Total assets | 31.0 | 55.0 | 88.0 | 80.5 | 82.1 | 6.4 | 33.5 | 16.9 | 16.6 | 46.0 | 26.3 | 20.9 | 6.2 | 19.4 | 78.3 | 145.4 | |
| Current liabilities | 11.2 | 15.9 | 62.5 | 27.2 | 57.1 | 5.8 | 24.6 | 6.0 | 5.3 | 12.3 | 5.0 | 15.5 | 13.7 | 9.5 | 7.0 | 7.6 | |
| Long-term debt | — | 0.0 | 7.7 | 4.5 | 0.0 | — | 2.6 | 0.0 | — | — | — | — | — | — | — | — | |
| Short-term debt | 0.5 | 0.0 | 2.1 | 3.9 | 4.7 | 16.4 | 8.4 | 0.0 | — | — | — | — | — | — | — | — | |
| Total liabilities | 20.9 | 27.2 | 82.1 | 43.4 | 68.6 | 11.4 | 31.5 | 11.7 | 10.5 | 18.1 | 5.9 | 16.1 | 14.2 | 10.0 | 7.5 | 7.7 | |
| Shareholders' equity | 10.1 | 27.8 | 5.9 | 37.1 | -12.3 | -5.0 | 2.1 | 5.2 | 6.1 | 28.0 | 20.3 | 4.9 | -8.0 | 9.5 | 70.9 | 137.7 |
USD millions · SEC XBRL
SELLAS Life Sciences Group, Inc. — questions
- How much cash does SELLAS Life Sciences Group, Inc. have?
- $138.3M in cash and cash equivalents as of 2026-06-30.
- What are SELLAS Life Sciences Group, Inc.'s total assets?
- $145.4M as of 2026-06-30.
- What is SELLAS Life Sciences Group, Inc.'s shareholders' equity?
- $137.7M as of 2026-06-30.
Every figure on this page comes from SELLAS Life Sciences Group, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.